These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 10459807

  • 1. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains.
    Maesaki S, Marichal P, Vanden Bossche H, Sanglard D, Kohno S.
    J Antimicrob Chemother; 1999 Jul; 44(1):27-31. PubMed ID: 10459807
    [Abstract] [Full Text] [Related]

  • 2. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
    Maesaki S, Marichal P, Hossain MA, Sanglard D, Vanden Bossche H, Kohno S.
    J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 4. [Function and gene expression of the active efflux transporters in drug-resistant Candida albicans].
    Guo HJ, Xia ZD, Wu GL, Zhou H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):183-7. PubMed ID: 17344615
    [Abstract] [Full Text] [Related]

  • 5. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
    Rocha MFG, Bandeira SP, de Alencar LP, Melo LM, Sales JA, Paiva MAN, Teixeira CEC, Castelo-Branco DSCM, Pereira-Neto WA, Cordeiro RA, Sidrim JJC, Brilhante RSN.
    Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K, Niimi M, Kudoh M, Fischer FJ, Makimura K, Niimi K, Piper RJ, Uchida K, Arisawa M, Cannon RD, Yamaguchi H.
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [Abstract] [Full Text] [Related]

  • 7. Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant Candida albicans by Competitively Inhibiting Efflux Pump.
    Xu J, Liu R, Sun F, An L, Shang Z, Kong L, Yang M.
    Front Cell Infect Microbiol; 2019 May; 9():211. PubMed ID: 31281800
    [Abstract] [Full Text] [Related]

  • 8. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [Abstract] [Full Text] [Related]

  • 9. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.
    Karababa M, Coste AT, Rognon B, Bille J, Sanglard D.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3064-79. PubMed ID: 15273122
    [Abstract] [Full Text] [Related]

  • 10. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M, Morschhäuser J, Prasad R.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):206-14. PubMed ID: 15896319
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW, Cruz MC, Katiyar SK, Edlind TD.
    Antimicrob Agents Chemother; 1999 Aug 24; 43(8):1968-74. PubMed ID: 10428921
    [Abstract] [Full Text] [Related]

  • 12. [Species-specific differences in Rhodamine 6G accumulation of Candida isolates detected by flow cytometric analysis].
    Moon CJ, Shin JH, Kim DW, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW.
    Korean J Lab Med; 2009 Apr 24; 29(2):127-34. PubMed ID: 19411779
    [Abstract] [Full Text] [Related]

  • 13. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM, Ma ZP, Jia Y, Gao PH, Zhang JD, Wang Y, Xu YG, Wang L, Cao YY, Cao YB, Zhang LX, Jiang YY.
    Biochem Biophys Res Commun; 2008 Sep 05; 373(4):631-6. PubMed ID: 18601908
    [Abstract] [Full Text] [Related]

  • 14. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S, Rahkhoodaee F, Raymond M.
    Antimicrob Agents Chemother; 2009 Apr 05; 53(4):1344-52. PubMed ID: 19223631
    [Abstract] [Full Text] [Related]

  • 15. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S.
    Infect Disord Drug Targets; 2017 Apr 05; 17(3):178-184. PubMed ID: 28558643
    [Abstract] [Full Text] [Related]

  • 16. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD.
    J Antimicrob Chemother; 2004 Dec 05; 54(6):999-1006. PubMed ID: 15486081
    [Abstract] [Full Text] [Related]

  • 17. Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
    Shen H, An MM, Wang de J, Xu Z, Zhang JD, Gao PH, Cao YY, Cao YB, Jiang YY.
    Biol Pharm Bull; 2007 Jan 05; 30(1):68-73. PubMed ID: 17202662
    [Abstract] [Full Text] [Related]

  • 18. Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.
    Stringaro A, Molinari A, Calcabrini A, Arancia G, Ceddia PG, Cianfriglia M, Poloni F, Mondello F, Angiolella L, De Bernardis F, Cassone A.
    Microb Drug Resist; 2002 Jan 05; 8(3):235-44. PubMed ID: 12363014
    [Abstract] [Full Text] [Related]

  • 19. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
    Sun LM, Liao K, Liang S, Yu PH, Wang DY.
    J Appl Microbiol; 2015 Apr 05; 118(4):826-38. PubMed ID: 25641229
    [Abstract] [Full Text] [Related]

  • 20. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ.
    J Med Vet Mycol; 1997 Apr 05; 35(2):133-7. PubMed ID: 9147273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.